Your browser doesn't support javascript.
loading
Communicating about COVID-19 vaccine development and safety.
Thorpe, Alistair; Fagerlin, Angela; Butler, Jorie; Stevens, Vanessa; Drews, Frank A; Shoemaker, Holly; Riddoch, Marian S; Scherer, Laura D.
Afiliação
  • Thorpe A; Spencer Fox Eccles School of Medicine at University of Utah, Salt Lake City, UT, United States of America.
  • Fagerlin A; Spencer Fox Eccles School of Medicine at University of Utah, Salt Lake City, UT, United States of America.
  • Butler J; Salt Lake City VA Informatics Decision-Enhancement and Analytic Sciences (IDEAS) Center for Innovation, Salt Lake City, UT, United States of America.
  • Stevens V; Spencer Fox Eccles School of Medicine at University of Utah, Salt Lake City, UT, United States of America.
  • Drews FA; Salt Lake City VA Informatics Decision-Enhancement and Analytic Sciences (IDEAS) Center for Innovation, Salt Lake City, UT, United States of America.
  • Shoemaker H; Geriatrics Research, Education, and Clinical Center (GRECC), VA Salt Lake City Health Care System, Salt Lake City, UT, United States of America.
  • Riddoch MS; Spencer Fox Eccles School of Medicine at University of Utah, Salt Lake City, UT, United States of America.
  • Scherer LD; Salt Lake City VA Informatics Decision-Enhancement and Analytic Sciences (IDEAS) Center for Innovation, Salt Lake City, UT, United States of America.
PLoS One ; 17(8): e0272426, 2022.
Article em En | MEDLINE | ID: mdl-35930557
ABSTRACT

PURPOSE:

Beliefs that the risks from a COVID-19 vaccine outweigh the risks from getting COVID-19 and concerns that the vaccine development process was rushed and lacking rigor have been identified as important drivers of hesitancy and refusal to get a COVID-19 vaccine. We tested whether messages designed to address these beliefs and concerns might promote intentions to get a COVID-19 vaccine.

METHOD:

We conducted an online survey fielded between March 8-23, 2021 with US Veteran (n = 688) and non-Veteran (n = 387) respondents. In a between-subjects experiment, respondents were randomly assigned to a control group (with no message) or to read one of two intervention messages 1. a fact-box styled message comparing the risks of getting COVID-19 compared to the vaccine, and 2. a timeline styled message describing the development process of the COVID-19 mRNA vaccines.

RESULTS:

Most respondents (60%) wanted a COVID-19 vaccine. However, 17% expressed hesitancy and 23% did not want to get a COVID-19 vaccine. The fact-box styled message and the timeline message did not significantly improve vaccination intentions, F(2,358) = 0.86, p = .425, [Formula see text] = .005, or reduce the time respondents wanted to wait before getting vaccinated, F(2,306) = 0.79, p = .453, [Formula see text] = .005, compared to no messages.

DISCUSSION:

In this experimental study, we did not find that providing messages about vaccine risks and the development process had an impact on respondents' vaccine intentions. Further research is needed to identify how to effectively address concerns about the risks associated with COVID-19 vaccines and the development process and to understand additional factors that influence vaccine intentions.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Comunicação em Saúde / Vacinas contra COVID-19 / COVID-19 / Desenvolvimento de Vacinas Tipo de estudo: Clinical_trials / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Comunicação em Saúde / Vacinas contra COVID-19 / COVID-19 / Desenvolvimento de Vacinas Tipo de estudo: Clinical_trials / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos